VR study reveals how limb disuse warps your sense of reach
NCT ID NCT07349173
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study uses virtual reality to explore how people with upper limb exclusion (non-use of an arm or hand) perceive the space around them. Researchers will compare 60 participants—those with the condition and healthy controls—as they judge whether virtual objects are reachable. The goal is to understand if the brain's map of reachable space shrinks due to limb disuse.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
he study population consists of two groups recruited at the Institut Régional de Réadaptation (Centre Louis Pierquin, UGECAM Nord-Est) in Nancy, France. Patients with Exclusion: Participants are selected from patients receiving routine care (full hospitalization or day hospital) at the center. They are identified based on a functional assessment ("Bilan 400 points") showing specific impairments related to unilateral upper limb exclusion evolving for more than 3 months. Healthy Controls: Asymptomatic volunteers are recruited through the social or family network of the investigators and current participants, as well as via posters displayed in the UGECAM centers.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria (patients): * Age ≥ 18 years. * Presenting unilateral exclusion symptom of the upper limb or part of the hand evolving for \> 3 months. * No contraindication to force work in daily activities. * For patients with finger exclusion: at least 2 perturbed items related to exclusion on tests 3 and 4 of the "Bilan 400 points". * Affiliated to a social security scheme. * Able to understand simple orders. Inclusion Criteria (Controls): * Age ≥ 18 years. * No history of upper limb impairment with sequelae. Exclusion Criteria (All): * Visual impairments. * Central neurological pathology. * Unstabilized psychiatric pathology. * Communication or comprehension difficulties. * Under legal protection or unable to consent. * Pregnant or breastfeeding women. * Cervical pathology contraindicating VR headset use. * Epilepsy. * Upper limb pathology unrelated to exclusion. * Inability to stand for 40 minutes.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Complex regional pain syndrome (CRPS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Institut Régional de Médecine Physique et de Réadaptation (IRR), Centre Louis Pierquin.
RECRUITINGNancy, 54000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.